Results 11 to 20 of about 12,068 (157)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME

Рациональная фармакотерапия в кардиологии, 2015
Aim. To compare efficacy of bisoprolol and bisoprolol+metformin combination in patients with arterial hypertension (AH) and metabolic syndrome (MS).Material and methods. 20 patients with AH and MS were involved in the study.
V. A. Nevzorova, N. V. Zakcharchuk, O. V. Nastradin, O. G. Pomogalova   +3 more
doaj   +3 more sources

NOVEL POTENTIAL DRUG INTERACTIONS WITH BISOPROLOL IN HOSPITALIZED ACUTE CORONARY SYNDROME PATIENTS [PDF]

Bulletin of Pharmaceutical Sciences. Assiut University
Objectives: Drug-drug interactions (DDI) pose a real challenge especially in patients with complicated therapeutic regimens such as acute coronary syndrome (ACS) patients.
Sherouk Okda, Amira Kassem, Ahmed Mahmoud Elamrawy, Ahmad Salahuddin, sohila Elonsy, Noha El-Bassiouny   +5 more
doaj   +1 more source

THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE

Рациональная фармакотерапия в кардиологии, 2016
Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure, rhythm disorders) are presented.
Yu. V. Lukina, S. Yu. Martsevich
doaj   +1 more source

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers

Journal of Cardiothoracic Surgery, 2023
Background Postoperative atrial fibrillation (POAF) after open-heart surgery is a non-negligible complication. We aimed to describe the efficacy of a transdermal patch of bisoprolol for managing POAF and flutter in thoracic surgical procedures.
Kenji Yamamoto, Senri Miwa, Tomoyuki Yamada, Shuji Setozaki, Mamoru Hamuro, Shunji Kurokawa, Sakae Enomoto   +6 more
doaj   +1 more source

EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY

Рациональная фармакотерапия в кардиологии, 2016
Aim. To study influence of ivabradine as compared with bisoprolol on clinical and hemodynamic indices, exercise tolerance, endothelial function, quality of life (QL) and erectile function in patients with ischemic heart disease. Material and methods.
R. D. Kurbanov, A. O. Kan, F. M. Bekmetova, A. B. Shek   +3 more
doaj   +1 more source

The effect of rs776746 polymorphism in the CYP3A5 gene on heart rate when using bisoprolol in patients with acute coronary syndrome

Рациональная фармакотерапия в кардиологии, 2022
Aim. The aim of this work was to study the occurrence of the rs776746 allelic variant of the CYP3A5 gene and its effect on heart rate (HR) when using bisoprolol in patients hospitalized with acute coronary syndrome (ACS).Materials and methods.
V. A. Shumkov, K. A. Zagorodnikova, S. A. Boldueva, A. A. Murzina   +3 more
doaj   +1 more source

Novel potentiometric methods for the estimation of bisoprolol and alverine in pharmaceutical forms and human serum

Reviews in Analytical Chemistry, 2021
Two new potentiometric sensors were created for the quantification of bisoprolol fumarate and alverine citrate in bulk pharmaceutical dosage forms and human serum.
Elgendy Khaled, Elmosallamy Mohamed A.F., Soltan Moustafa K., Amin Alaa S., Elshaprawy Dina S.   +4 more
doaj   +1 more source

Assessment of the effect of -blockers on the functional state in patients with ventricular arrhythmias: results of a comparative study

КардиоСоматика, 2020
Aim.Compare the effects of bisoprolol, nebivolol and sotalol on the functional state of patients with ventricular arrhythmias (VA). Material and methods.120 patients with VA against the background of essential hypertension or its combination with ...
Iosif Z. Shubitidze, Vitalii G. Tregubov
doaj   +1 more source

Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare the efficacy and cost/effectiveness ratio of the original and generic bisoprolol in achieving target heart rate (HR) in patients with ischemic heart disease.Material and methods. Patients with ischemic heart disease (n=60; 36 males and 24
E. I. Tarlovskaya, T. I. Chudinovskikh
doaj   +1 more source

Comparative Analysis of Compendial Requirements for the Quality of Bisoprolol Products

Регуляторные исследования и экспертиза лекарственных средств
INTRODUCTION. Beta-blockers are one of the major groups of medicines used to treat cardiovascular diseases. Bisoprolol fumarate is of particular interest as it shows high selectivity towards beta-1 receptors.
O. A. Matveeva, E. L. Kovaleva, A. P. Karpushina, V. V. Akopova   +3 more
doaj   +1 more source